Anesthesiology, Pain Medicine · Erie, PA
NPI
1245271568
Since 2006
Specialty
Anesthesiology, Pain Medicine
Code 207LP2900X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
5442 Peach St
Erie, PA, 16509
Phone (814) 833-7246
Groups this clinician bills Medicare through
Medicare paid, 2024
$150K
25,539 services
Medicare patients, 2024
339
Average age 72
Drug cost, 2024
$525K
12,951 prescriptions
Company payments, 2025
$128
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joseph M Thomas was code Q9966 (low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml), 20,095 times for 210 patients. In total Joseph M Thomas billed 25,539 services in 38 codes, and Medicare paid $150K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-09-13.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | Office | 20,095 | 210 | $0.28 | $5,723 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2,179 | 239 | $0.76 | $1,645 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,854 | 228 | $0.09 | $160 |
| 99213 Office E&M - Established | Office | 233 | 151 | $55.17 | $13K |
| 99214 Office E&M - Established | Office | 179 | 131 | $80.88 | $14K |
| 64483 Nerve Block Injection - Back | Office | 158 | 92 | $179.59 | $28K |
| 62323 Nerve Block Injection - Back | Office | 117 | 80 | $166.17 | $19K |
| 20610 Joint Injection | Office | 77 | 47 | $44.36 | $3,416 |
| 77002 Imaging - Miscellaneous | Office | 72 | 45 | $75.06 | $5,405 |
| J2250 Injection, midazolam hydrochloride, per 1 mg | Office | 71 | 21 | $0.11 | $7.55 |
| 99204 Office E&M - New | Office | 39 | 39 | $102.68 | $4,004 |
| 64635 Destruction by Neurolytic Agent - Back | Office | 38 | 25 | $303.05 | $12K |
| 64484 Nerve Block Injection - Back | Office | 38 | 27 | $76.64 | $2,912 |
| 64636 Destruction by Neurolytic Agent - Back | Office | 38 | 25 | $166.74 | $6,336 |
| 64493 Nerve Block Injection - Back | Office | 36 | 19 | $161.40 | $5,810 |
By year: 2022 $226K for 30,075 services; 2023 $185K for 22,062 services; 2024 $150K for 25,539 services.
Medicare prescription drug claims, 2024
In 2024, the drug Joseph M Thomas prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 4,508 prescriptions and refills. In total Joseph M Thomas wrote 12,951 Medicare prescriptions that cost $525K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 4,508 | 4,514 | 583 | $72K |
| Gabapentin Generic | 1,006 | 1,284 | 209 | $15K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 776 | 776 | 152 | $14K |
| Tizanidine Hcl Generic | 723 | 761 | 176 | $4,955 |
| Tramadol Hcl Generic | 509 | 523 | 124 | $2,598 |
| Buprenorphine Generic | 456 | 456 | 82 | $94K |
| Carisoprodol Generic | 450 | 461 | 59 | $3,502 |
| Pregabalin Generic | 449 | 495 | 72 | $8,190 |
| Celecoxib Generic | 348 | 431 | 116 | $7,106 |
| Cyclobenzaprine Hcl Generic | 310 | 326 | 71 | $1,744 |
| Diazepam Generic | 257 | 257 | 135 | $252 |
| Belbuca Buprenorphine Hcl | 247 | 248 | 51 | $149K |
| Duloxetine Hcl Generic | 218 | 394 | 60 | $2,700 |
| Oxycodone Hcl Generic | 214 | 214 | 46 | $2,221 |
| Methocarbamol Generic | 197 | 203 | 43 | $1,943 |
Brand drugs: 525 claims; generic drugs: 12,426 claims; opioid claims: 7,288.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joseph M Thomas $128 ($128 in general payments such as food, travel and fees) from 4 companies. The largest payer was Vertex Pharmaceuticals Incorporated with $39.62.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.